• Skip to main content
BC

biochimica clinica

en_US English
en_US English it_IT Italian
  • Home
  • Casi clinici
  • Ahead of print e Ultimo Fascicolo - Accedi per visualizzare gli articoli
  • Archivio BC fino a 2024
  • Sottometti un articolo
  • Norme Autori
  • Cerca

DOCUMENTI - Documents

Volume:

Biochimica Clinica 2018; 42(1) 51-61

Pubblicato on-line:

January 19, 2018

DOI:

10.19186/BC_2018.004

Scarica in PDF:
Autenticazione richiesta

Validazione dei metodi quantitativi bioanalitici in spettrometria di massa: regole e protocolli sperimentali

AUTORI

Antonio D’Avolio1, Marco Cantù2, Jacopo Gervasoni3, Carlo Artusi4, Mariela Marinova4, Antonello Nonnato5, Giuliana Cangemi6, Silvia Persichilli3 per il Gruppo di Studio SIBioC - Medicina di Laboratorio “La spettrometria di massa: applicazioni e innovazioni diagnostiche”
1Laboratorio di Farmacologia Clinica e di Farmacogenetica, Ospedale Amedeo di Savoia, Dipartimento di Scienze Mediche, Università di Torino
2Laboratorio di Biochimica e Farmacologia Clinica, Dipartimento di Medicina di Laboratorio EOLAB, Ente Ospedaliero Cantonale, Bellinzona, Svizzera
3UOC Chimica Clinica, Fondazione Policlinico Universitario A. Gemelli, Università Cattolica del Sacro Cuore, Roma
4Dipartimento di Medicina di Laboratorio, Azienda Ospedaliero-Universitaria, Padova
5Unità di Biochimica Clinica, Dipartimento di Diagnostica di Laboratorio, Azienda Ospedaliero-Universitaria “Città della Salute e della Scienza”, Torino
6Laboratorio di Patologia Clinica, Istituto Giannina Gaslini, Genova

ABSTRACT

Bioanalytical method validation of quantitative mass spectrometry based assay: experimental protocols and regulations

Liquid chromatography-mass spectrometry (LC-MS) technique has rapidly extended the spectrum of clinical chemistry methods during the past decade and it has became a standard tool for endogenous and exogenous substances in research laboratories as well as in many clinical laboratories. To date, many guidelines for bioanalytical method validation have been published, but there is still the need to have specific guidelines and experimental protocols. In particular, we need to further focus and investigate the overall clinical aspects of spectrometry method validation, for both exogenous and endogenous molecules. The aim of the present document is to suggest specific experimental regulations and protocols for bioanalytical LC-MS method validation for exogenous and endogenous molecules, inspired by actual international guidelines and integrated with practical tips to obtain better performance on methods used in routine clinical practice. Here we have introduced new concepts such as “normalized matrix effect”, and protocols for method validation using “pathological samples” and “altered samples”, as these are the most commonly samples encountered in laboratory routine. In conclusion, the new rules and protocols reported in this work do not intend to replace international guidelines; we believe that these rules have to be considered besides the available guidelines with the aim to help the LC-MS users by recommending a number of experimental steps to be performed during each method/kit validation.

BIBLIOGRAFIA

HOME
PRIVACY POLICY
5x1000 Docemus

LOGO SIBioC

EDITORE RESPONSABILE
Alberto Oliaro

EDITORIAL SECRETARY
Edizioni Minerva Medica S.p.A.
Corso Bramante 83-85, 10126 Torino
T +39 011 678282
journals.dept@minervamedica.it

Designed by Biomedia srl
© 2025 SIBioC
P. IVA IT 06484860967